Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angela Dispenzieri

Showing results (731-740 of 759) with videos related to

Pageof 76
Sort By:
Blood Cancer Journal|April 4, 2025
Venetoclax-based treatment combinations in relapsed/refractory multiple myeloma: practice patterns and impact of secondary cytogenetic abnormalities on outcomesAbiola Bolarinwa, Madhu Nagaraj, Saurabh Zanwar, et al.
American Journal of Hematology|April 28, 2021
Assessment of fixed-duration therapies for treatment-naïve Waldenström macroglobulinemiaJithma P Abeykoon, Saurabh Zanwar, Stephen M Ansell, et al.
The New England Journal of Medicine|September 4, 2014
Lenalidomide and dexamethasone in transplant-ineligible patients with myelomaLotfi Benboubker, Meletios A Dimopoulos, Angela Dispenzieri, et al.
Nature Reviews. Nephrology|December 5, 2018
The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research GroupNelson Leung, Frank Bridoux, Vecihi Batuman, et al.
American Journal of Hematology|October 29, 2017
MYD88 mutation status does not impact overall survival in Waldenström macroglobulinemiaJithma P Abeykoon, Jonas Paludo, Rebecca L King, et al.
Blood|July 26, 2023
Impact of cytogenetic abnormalities on the risk of disease progression in solitary bone plasmacytomasUdit Yadav, Shaji K Kumar, Linda B Baughn, et al.
Nature Reviews. Nephrology|December 21, 2018
Publisher Correction: The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research GroupNelson Leung, Frank Bridoux, Vecihi Batuman, et al.
Mayo Clinic Proceedings|August 6, 2025
Heart Transplantation for Cardiac Amyloidosis: Mayo Clinic Consensus StatementMelissa A Lyle, Julie L Rosenthal, Jose N Nativi Nicolau, et al.
American Journal of Hematology|April 7, 2017
IgM myeloma: A multicenter retrospective study of 134 patientsJorge J Castillo, Artur Jurczyszyn, Lucie Brozova, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 16, 2015
Improved Outcomes After Autologous Hematopoietic Cell Transplantation for Light Chain Amyloidosis: A Center for International Blood and Marrow Transplant Research StudyAnita D'Souza, Angela Dispenzieri, Baldeep Wirk, et al.
Pageof 76

Showing results (731-740 of 759) with videos related to

Sort By:
Pageof 76
Blood Cancer Journal|April 4, 2025
Venetoclax-based treatment combinations in relapsed/refractory multiple myeloma: practice patterns and impact of secondary cytogenetic abnormalities on outcomesAbiola Bolarinwa, Madhu Nagaraj, Saurabh Zanwar, et al.
American Journal of Hematology|April 28, 2021
Assessment of fixed-duration therapies for treatment-naïve Waldenström macroglobulinemiaJithma P Abeykoon, Saurabh Zanwar, Stephen M Ansell, et al.
The New England Journal of Medicine|September 4, 2014
Lenalidomide and dexamethasone in transplant-ineligible patients with myelomaLotfi Benboubker, Meletios A Dimopoulos, Angela Dispenzieri, et al.
Nature Reviews. Nephrology|December 5, 2018
The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research GroupNelson Leung, Frank Bridoux, Vecihi Batuman, et al.
American Journal of Hematology|October 29, 2017
MYD88 mutation status does not impact overall survival in Waldenström macroglobulinemiaJithma P Abeykoon, Jonas Paludo, Rebecca L King, et al.
Blood|July 26, 2023
Impact of cytogenetic abnormalities on the risk of disease progression in solitary bone plasmacytomasUdit Yadav, Shaji K Kumar, Linda B Baughn, et al.
Nature Reviews. Nephrology|December 21, 2018
Publisher Correction: The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research GroupNelson Leung, Frank Bridoux, Vecihi Batuman, et al.
Mayo Clinic Proceedings|August 6, 2025
Heart Transplantation for Cardiac Amyloidosis: Mayo Clinic Consensus StatementMelissa A Lyle, Julie L Rosenthal, Jose N Nativi Nicolau, et al.
American Journal of Hematology|April 7, 2017
IgM myeloma: A multicenter retrospective study of 134 patientsJorge J Castillo, Artur Jurczyszyn, Lucie Brozova, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 16, 2015
Improved Outcomes After Autologous Hematopoietic Cell Transplantation for Light Chain Amyloidosis: A Center for International Blood and Marrow Transplant Research StudyAnita D'Souza, Angela Dispenzieri, Baldeep Wirk, et al.
Pageof 76